Peter Krebser
Chairman at Basel Area Business & Innovation
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Domenico Scala | M | 59 |
Basel Area Business & Innovation
| 9 years |
| Adrian Bult | M | 65 |
Basel Area Business & Innovation
| 8 years |
| Peter J. Uggowitzer | M | 73 |
Swiss Federal Institute of Technology
| 43 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Karl W. Gschwend | M | 71 |
Swiss Federal Institute of Technology
| 9 years |
| Ernst A. Häberli | M | 75 |
Swiss Federal Institute of Technology
| 4 years |
| Walter Blättler | M | 75 |
Swiss Federal Institute of Technology
| 5 years |
| Gian-Luca Bona | M | 67 |
Swiss Federal Institute of Technology
| 8 years |
| François Meyer | M | 76 |
Sandoz Pharmaceuticals AG
 Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland.
Swiss Federal Institute of Technology
| 8 years |
| Karl Landert | M | 65 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.
Swiss Federal Institute of Technology
| 8 years |
| Michel Liès | M | 70 |
Swiss Federal Institute of Technology
| 4 years |
| Max E. Link | M | 84 |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | 22 years |
| Sergio Magistri | M | - |
Swiss Federal Institute of Technology
| 8 years |
| Victor Waldemar Balli | M | 67 |
Swiss Federal Institute of Technology
| 5 years |
| Lukas Braunschweiler | M | 68 |
Swiss Federal Institute of Technology
| 4 years |
| Periclès–Paul P. Petalas | M | 81 |
Swiss Federal Institute of Technology
| 1 years |
| Jost Krüttli | M | 73 |
Swiss Federal Institute of Technology
| 4 years |
| Erich Hunziker | M | 70 |
Swiss Federal Institute of Technology
| 3 years |
| Mehmet Tara | M | 66 |
Swiss Federal Institute of Technology
| 4 years |
| Thomas Kissel | M | - |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | 13 years |
| Beat In-Albon | M | 72 |
Lonza AG
 Lonza AG BiotechnologyHealth Technology Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland. | 35 years |
| Ernesto Schümperli | M | 68 |
Swiss Federal Institute of Technology
| 4 years |
| Peter Baumann | M | 68 |
Swiss Federal Institute of Technology
| 4 years |
| Michel Perraudin | M | 78 |
Swiss Federal Institute of Technology
| 4 years |
| Hans-Rudolf Spiess | M | 75 |
Swiss Federal Institute of Technology
| 3 years |
| Felix Bärlocher | M | 76 |
Swiss Federal Institute of Technology
| 4 years |
| Alexander Jakob Boris Zehnder | M | - |
Swiss Federal Institute of Technology
| 3 years |
| Peter H. Müller | M | 74 |
Swiss Federal Institute of Technology
| 1 years |
| Fritz Gantert | M | 66 |
Swiss Federal Institute of Technology
| 5 years |
| Peter Gnägi | M | 70 |
Swiss Federal Institute of Technology
| 4 years |
| Pierre-François Veillon | M | 74 |
Swiss Federal Institute of Technology
| 1 years |
| Juerg Winter | M | - |
Swiss Federal Institute of Technology
| 3 years |
| Thomas Villiger | M | 73 |
Swiss Federal Institute of Technology
| 3 years |
| Ulrich Schaumann | M | 67 |
Swiss Federal Institute of Technology
| 3 years |
| Caroline Geuissaz | F | - |
Swiss Federal Institute of Technology
| 4 years |
| Markus Heusler | M | 65 |
Swiss Federal Institute of Technology
| 4 years |
| Dominique Durant des Aulnois | M | - |
Swiss Federal Institute of Technology
| 4 years |
| Hans Brändle | M | 63 |
Swiss Federal Institute of Technology
| 14 years |
| Jacques de Saussure | M | - |
Swiss Federal Institute of Technology
| 4 years |
| Laurent Vulliet | M | 66 |
Swiss Federal Institute of Technology
| 4 years |
| Claude Flueckiger | M | - |
Swiss Federal Institute of Technology
| 3 years |
| Paul Sekhri | M | 66 |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | - |
| Eric Cornut | M | 67 |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | 1 years |
| Peter Pleus | M | - |
Swiss Federal Institute of Technology
| 3 years |
| Simon Jones | M | - |
Swiss Federal Institute of Technology
| 4 years |
| Ioannis Panagiotis Votsaridis | M | 73 |
Swiss Federal Institute of Technology
| 4 years |
| Veli Ergin Imre | M | 66 |
Swiss Federal Institute of Technology
| 4 years |
| Alfons Traxler | M | - |
Swiss Federal Institute of Technology
| 4 years |
| Jean-Daniel Borgeaud | M | 66 |
Swiss Federal Institute of Technology
| 4 years |
| Jakob Züger | M | 72 |
Swiss Federal Institute of Technology
| 1 years |
| Per-Olof Attinger | M | 64 |
Swiss Federal Institute of Technology
| 4 years |
| Paul Herrling | M | 78 |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | - |
| Felix Rudolf | M | 74 |
Swiss Federal Institute of Technology
| 4 years |
| Alexis Fries | M | 69 |
Swiss Federal Institute of Technology
| 1 years |
| Jean-Pierre Obrecht | M | - |
Swiss Federal Institute of Technology
| 3 years |
| Rolf Soiron | M | 79 |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | 1 years |
| Jens Alder | M | 67 |
Swiss Federal Institute of Technology
| 1 years |
| Andreas Niklaus Koopmann-Zulliger | M | 73 |
Swiss Federal Institute of Technology
| 1 years |
| Stefan Mario Meister | M | 58 |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | - |
| Bruno E. Raschle | M | - |
Swiss Federal Institute of Technology
| 4 years |
| Martin Bachmann | M | 65 |
Swiss Federal Institute of Technology
| 5 years |
| Christophe Jean | M | 67 |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | 3 years |
| Norbert W. Bischofberger | M | 68 |
Swiss Federal Institute of Technology
| 3 years |
| Beat Siegrist | M | 64 |
Swiss Federal Institute of Technology
| 5 years |
| Armin Meyer | M | 75 |
Swiss Federal Institute of Technology
| 3 years |
| Argeris Karabelas | M | 71 |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | 2 years |
| Christoph Alexander Schoeller | M | 65 |
Swiss Federal Institute of Technology
| 4 years |
| Pierre de Weck | M | 73 |
Swiss Federal Institute of Technology
| 1 years |
| Bernhard Jucker | M | 70 |
Swiss Federal Institute of Technology
| 4 years |
| Jean-Christophe Hadorn | M | 67 |
Swiss Federal Institute of Technology
| 1 years |
| Daniel Crausaz | M | 67 |
Swiss Federal Institute of Technology
| 4 years |
| Carl Erik Steen | M | 74 |
Swiss Federal Institute of Technology
| 1 years |
| Erwin Stoller | M | 77 |
Swiss Federal Institute of Technology
| 1 years |
| Claudio Albrecht | M | 64 |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | - |
| George P. Sagredos | M | 71 |
Swiss Federal Institute of Technology
| 1 years |
| Beat E. Lüthi | M | 62 |
Swiss Federal Institute of Technology
| 6 years |
| Giovanni Müller | M | - |
Swiss Federal Institute of Technology
| 4 years |
| Massimo Arnoldi | M | - |
Swiss Federal Institute of Technology
| 4 years |
| Romain Becker | M | 70 |
Swiss Federal Institute of Technology
| 4 years |
| Peter Leupp | M | 72 |
Swiss Federal Institute of Technology
| 4 years |
| Antonio Matteo Taormina | M | 76 |
Swiss Federal Institute of Technology
| 4 years |
| Niklaus Peter Nüesch | M | 70 |
Swiss Federal Institute of Technology
| 7 years |
| Heinrich Andreas Baumann | M | 72 |
Swiss Federal Institute of Technology
| 4 years |
| Philippe Weigerstorfer | M | 64 |
Sandoz Pharmaceuticals AG
Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | - |
| Jürg Spillmann | M | - |
Swiss Federal Institute of Technology
| 4 years |
| Reto Crameri | M | - |
Swiss Federal Institute of Technology
| 3 years |
| Jürg Oleas | M | 67 |
Swiss Federal Institute of Technology
| 1 years |
| Duccio Alberti | M | 72 |
Swiss Federal Institute of Technology
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Switzerland | 87 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Krebser
- Personal Network
